Speaker illustration

Doctor Tong Liu

Tianjin Medical University, Tianjin (China)

Member of:

European Society of Cardiology
Heart Failure Association

I currently served as Professor of Cardiology in Tianjin Medical University; Deputy director of Tianjin Institute of Cardiology and an electrophysiologist in Department of Cardiology, Second Hospital of Tianjin Medical University, 300211, Tianjin, P.R. China. My current interests concern the study of atrial fibrillation and arrhythmias. Secondly. I also participate in some researches in the field of Cardio-oncology and heart failure. Furthermore, I have participated in several clinical research protocols that cover a wide range of issues in Cardiology and Internal Medicine. I have published more than 200 papers in Peer-reviewed medical journals, including 110 papers with first/co-first/corresponding/co-corresponding authors. I am on the editorial board of Pacing Clin Electrophysiol, BMC Cardiovascular Disorders, Cardiovascular Diagnosis and Therapy, Frontiers in Physiology, BioMed Research International, Cardiology Research Practice.

IP3R1/GRP75/VDAC1 complex mediated endoplasmic reticulum stress-mitochondrial oxidative stress in diabetic atrial remodeling

Event: EHRA 2021

Topic: Arrhythmias

Session: Pathophysiology of arrhythmias

Thumbnail

Three-dimensional vectorcardiographic characteristics of breast cancer patients treated with chemotherapy

Event: EHRA 2021

Topic: Electrocardiography (ECG)

Session: ePoster session

Thumbnail

Cancer and risk of atrial fibrillation: a systematic review and meta-analysis.

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: Comorbidities and mortalities

Thumbnail

Alogliptin, a DPP-4 inhibitor, alleviates atrial remodeling and improves mitochondrial function and biogenesis in diabetic rabbits

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: Atrial fibrillation obesity

Thumbnail

Rapamycin attenuates atrial fibrosis in 5/6 nephrectomized rats by inhibiting mTOR and pro-fibrotic signaling.

Event: ESC CONGRESS 2017

Topic: Antiarrhythmic drugs

Session: Drug treatment

Thumbnail

Excessive supraventricular ectopic activity and adverse cardiovascular outcomes: a systematic review and meta-analysis.

Event: ESC CONGRESS 2017

Topic: Supraventricular arrhythmias (excluding AF)

Session: Supraventricular arrhythmias

Thumbnail

Xanthine oxidase inhibition prevents atrial remodeling and atrial fibrillation in alloxan-induced diabetic rabbits

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session: Mechanism of arrhythmia

Thumbnail

Linear ablation following pulmonary vein isolation in patients with atrial fibrillation: a meta-analysis

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session: Atrial fibrillation ablation: novelties and advances

Thumbnail

This platform is supported by

logo Novo Nordisk